|
|
Volumn 4, Issue 12, 2005, Pages 787-
|
|
The hard way to a Bill of Rights
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
ROFECOXIB;
CLINICAL TRIAL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SCREENING;
EDITORIAL;
HUMAN;
HUMAN RIGHTS;
LEGAL ASPECT;
MEDICAL ETHICS;
MEDICAL LITERATURE;
MEDICAL RESEARCH;
NEUROTOXICITY;
PARKINSON DISEASE;
PATENT;
PRIORITY JOURNAL;
SIDE EFFECT;
ANIMALS;
CLINICAL TRIALS;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
HEALTH SERVICES ACCESSIBILITY;
HUMAN RIGHTS;
HUMANS;
PARKINSON DISEASE;
PATIENT ADVOCACY;
PATIENT RIGHTS;
UNITED STATES;
|
|
EID: 47249130458
PISSN: 14744422
EISSN: None
Source Type: Journal
DOI: 10.1016/S1474-4422(05)70228-3 Document Type: Editorial |
|
Times cited : (7)
|
|
References (0)
|